M
Michelle S. Hirsch
Researcher at Brigham and Women's Hospital
Publications - 216
Citations - 12734
Michelle S. Hirsch is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Cancer & Renal cell carcinoma. The author has an hindex of 51, co-authored 193 publications receiving 10469 citations. Previous affiliations of Michelle S. Hirsch include Becton Dickinson & Peter MacCallum Cancer Centre.
Papers
More filters
Journal ArticleDOI
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David Kindelberger,Yonghee Lee,Alexander Miron,Michelle S. Hirsch,Colleen M. Feltmate,Fabiola Medeiros,Michael J. Callahan,Elizabeth I.O. Garner,Robert W. Gordon,Chandler Birch,Ross S. Berkowitz,Michael G. Muto,Christopher P. Crum +12 more
TL;DR: TIC coexists with all forms of pelvic serous carcinoma and is a plausible origin for many of these tumors, although further studies are needed to elucidate the etiologic significance.
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia
John R. Srigley,Brett Delahunt,John N. Eble,Lars Egevad,Jonathan I. Epstein,David J. Grignon,Ondrej Hes,Holger Moch,Rodolfo Montironi,Satish K. Tickoo,Ming Zhou,Pedram Argani,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Ferran Algaba,Robert W. Allan,Mahul B. Amin,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,John C. Cheville,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Peter A. Humphrey,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Cristina Magi-Galluzzi,Guido Martignoni,Teresa McHale,Jesse K. McKenney,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Hemamali Samaratunga,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Pheroze Tamboli,Puay Hoon Tan,Isabel Trias,Kiril Trpkov,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Debra L. Zynger +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt,John C. Cheville,Guido Martignoni,Peter A. Humphrey,Cristina Magi-Galluzzi,Jesse K. McKenney,Lars Egevad,Ferran Algaba,Holger Moch,David J. Grignon,Rodolfo Montironi,John R. Srigley,John R. Srigley,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Robert W. Allan,Mahul B. Amin,Pedram Argani,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Jonathan I. Epstein,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Ondrej Hes,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Teresa McHale,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Puay Hoon Tan,Satish K. Tickoo,Isabel Trias,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Ming Zhou,Debra L. Zynger +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.
Journal ArticleDOI
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile,Kristopher A. Sarosiek,Thanh Trang T. Vo,Jeremy Ryan,Anupama Tammareddi,Victoria Del Gaizo Moore,Jing Deng,Kenneth C. Anderson,Paul G. Richardson,Yu-Tzu Tai,Constantine S. Mitsiades,Ursula A. Matulonis,Ronny Drapkin,Ronny Drapkin,Richard Stone,Daniel J. DeAngelo,David J. McConkey,Stephen E. Sallan,Lewis B. Silverman,Michelle S. Hirsch,Daniel R. Carrasco,Anthony Letai +21 more
TL;DR: It is shown that clinical response to cytotoxic chemotherapy correlates with, and may be partially governed by, the pretreatment proximity of tumor cell mitochondria to the apoptotic threshold, a property called mitochondrial priming.
Journal ArticleDOI
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy,S. Intidhar Labidi-Galy,Eniko Papp,Dorothy Hallberg,Noushin Niknafs,Noushin Niknafs,Vilmos Adleff,Michaël Noë,Rohit Bhattacharya,Rohit Bhattacharya,Marian Novak,Siân Jones,Jillian Phallen,Carolyn Hruban,Michelle S. Hirsch,Douglas I. Lin,Douglas I. Lin,Lauren E. Schwartz,Cecile L. Maire,Jean-Christophe Tille,Michaela Bowden,Ayse Ayhan,Laura D. Wood,Robert B. Scharpf,Robert J. Kurman,Tian Li Wang,Ie Ming Shih,Rachel Karchin,Rachel Karchin,Ronny Drapkin,Ronny Drapkin,Ronny Drapkin,Victor E. Velculescu +32 more
TL;DR: Genetic aberrances in fallopian tube lesions, ovarian cancers, and metastases from HGSOC patients are analyzed and evolutionary analyses reveal that p53 signatures and STICs are precursors of ovarian carcinoma and identify a window of 7 years between development of a STIC and initiation of ovarian cancer, with metastases following rapidly thereafter.